Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?

Creative Commons License

Solmaz S., Uzun Ö., Acar C., Sevindik O. G., Piskin O., Ozsan H. G., ...Daha Fazla

Journal of laboratory physicians, cilt.10, sa.4, ss.363-369, 2018 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10 Sayı: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.4103/jlp.jlp_36_18
  • Dergi Adı: Journal of laboratory physicians
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI)
  • Sayfa Sayıları: ss.363-369
  • Anahtar Kelimeler: Multiple myeloma, neutrophil-to-lymphocyte ratio, new prognostic marker, platelet-to-lymphocyte ratio, PREDICTING SURVIVAL, NEUTROPHIL, COUNT
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

BACKGROUND: Recent reports showed neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), as a predictor of progression-free survival (PFS) and overall survival (OS) in various malignancies.